A Dose-Escalation Study of R1507 [RO4858696] in Patients With Advanced Solid Tumours.

Trial Profile

A Dose-Escalation Study of R1507 [RO4858696] in Patients With Advanced Solid Tumours.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 May 2013

At a glance

  • Drugs Teprotumumab (Primary)
  • Indications Hodgkin's disease; Non-Hodgkin's lymphoma; Solid tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 15 Jun 2010 Planned end date changed from 1 Jun 2009 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 21 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 19 Mar 2008 Status change from in progress to recruiting, according to clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top